Literature DB >> 17108352

Atazanavir urolithiasis.

Hernan R Chang, Pablo M Pella.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108352     DOI: 10.1056/NEJMc061892

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Medication-based urolithiasis and atazanavir.

Authors:  Paul M Koblic; Wayne L Gold; Charles J L la Porte; Todd C Lee
Journal:  CMAJ       Date:  2011-03-28       Impact factor: 8.262

Review 2.  HIV therapies and the kidney: some good, some not so good?

Authors:  Lene Ryom; Amanda Mocroft; Jens Lundgren
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 3.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

4.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Authors:  Lene Ryom; Amanda Mocroft; Ole Kirk; Signe W Worm; David A Kamara; Peter Reiss; Michael Ross; Christoph A Fux; Philippe Morlat; Olivier Moranne; Colette Smith; Jens D Lundgren
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

Review 5.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  Atazanavir: its role in HIV treatment.

Authors:  Robin Wood
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

Review 7.  Critical care of persons infected with the human immunodeficiency virus.

Authors:  Anuradha Ganesan; Henry Masur
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

8.  Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient.

Authors:  Yoji Moriyama; Yuzuru Minamidate; Mitsuru Yasuda; Hidetoshi Ehara; Mina Kikuchi; Tomohiro Tsuchiya; Takashi Deguchi; Hisashi Tsurumi
Journal:  Urol Res       Date:  2008-07-17

Review 9.  Antiretroviral therapy : pharmacokinetic considerations in patients with renal or hepatic impairment.

Authors:  Sarah M McCabe; Qing Ma; Judianne C Slish; Linda M Catanzaro; Neha Sheth; Robert DiCenzo; Gene D Morse
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Role of atazanavir in the treatment of HIV infection.

Authors:  Pablo Rivas; Judit Morello; Carolina Garrido; Sonia Rodríguez-Nóvoa; Vincent Soriano
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.